Compugen (CGEN) Operating Income Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Compugen | 234.03 Mn | 142.28 Mn | 352,000.00 | 7.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.41% |
| Dec 31, 2025 | 848.94% |
| Sep 30, 2025 | -275.56% |
| Jun 30, 2025 | -23.65% |
| Mar 31, 2025 | -1.14% |
| Dec 31, 2024 | -141.61% |
| Sep 30, 2024 | 142.30% |
| Jun 30, 2024 | 33.09% |
| Mar 31, 2024 | -16.20% |
| Dec 31, 2023 | 609.61% |
| Sep 30, 2023 | 12.97% |
| Dec 31, 2022 | 59.81% |
| Sep 30, 2022 | -92.83% |
| Dec 31, 2021 | 3.42% |
| Mar 31, 2021 | -38.74% |
| Dec 31, 2020 | -35.83% |
| Mar 31, 2020 | 13.11% |
| Dec 31, 2019 | 30.83% |
| Sep 30, 2019 | -100.03% |
| Jun 30, 2019 | 32.19% |
| Mar 31, 2019 | -7,503.48% |
| Dec 31, 2018 | -3.09% |
| Sep 30, 2018 | 66.61% |
| Jun 30, 2018 | -11.63% |
| Mar 31, 2018 | 101.31% |
| Dec 31, 2017 | -7.43% |
| Sep 30, 2017 | -25.25% |
| Jun 30, 2017 | -32.09% |
| Mar 31, 2017 | 0.99% |
| Dec 31, 2016 | -1,101.79% |
| Sep 30, 2016 | -15.23% |
| Jun 30, 2016 | -0.79% |
| Mar 31, 2016 | -40.32% |
| Dec 31, 2015 | 34.80% |
| Sep 30, 2015 | -50.53% |
| Jun 30, 2015 | -109.55% |
| Mar 31, 2015 | -90.94% |
| Dec 31, 2014 | 71.83% |
| Sep 30, 2014 | -4.34% |
| Jun 30, 2014 | 29.69% |
| Mar 31, 2014 | 16.47% |
| Dec 31, 2013 | -3.05% |
| Sep 30, 2013 | -21.47% |
| Jun 30, 2013 | -59.53% |
| Mar 31, 2013 | -27.09% |
| Dec 31, 2012 | -25.11% |
| Sep 30, 2012 | -16.64% |
| Jun 30, 2012 | 12.17% |
| Mar 31, 2012 | -28.14% |
| Dec 31, 2011 | -33.48% |
| Sep 30, 2011 | -61.57% |
| Jun 30, 2011 | -259.45% |
| Mar 31, 2011 | 10.45% |
| Dec 31, 2010 | -17.89% |
| Sep 30, 2010 | 4.99% |
| Jun 30, 2010 | 39.12% |
| Mar 31, 2010 | -28.51% |